2025
SJR Q2
JCR Q3 · 2,7
71 matched articles
SCIE
Journal detail
Neuropeptides
- Publisher
- Churchill Livingstone
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0143417915322785
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,786
- Quartile Q2
- H-Index 83
- Cites/doc 3,2
- Docs (3y) 151
- Cites (3y) 454
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,7
- 5Y JIF 2,7
- JCI 0,6
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cellular and Molecular Neuroscience Q3
- Endocrine and Autonomic Systems Q3
- Endocrinology Q3
- Medicine (miscellaneous) Q2
- Neurology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Neuroscience
WoS categories
- Endocrinology & Metabolism | Neurosciences
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,786 | 2,7 | 2,7 | 0,6 | Q3 | 83 |
| 2024 | Q2 | Q3 | 0,637 | 2,7 | 2,5 | 0,64 | Q3 | 82 |
| 2023 | Q2 | Q3 | 0,716 | 2,5 | 2,5 | 0,63 | Q3 | 82 |
| 2022 | Q2 | Q3 | 0,719 | 2,9 | 2,8 | 0,64 | Q3 | 82 |
| 2021 | Q2 | Q3 | 0,726 | 3,2 | 3,1 | 0,66 | Q3 | 82 |
| 2020 | Q2 | Q3 | 0,83 | 3,3 | 3,1 | 0,63 | Q3 | 82 |
| 2019 | Q2 | Q3 | 0,814 | 2,4 | 2,6 | 0,65 | Q3 | 82 |
| 2018 | — | Q3 | — | 2,4 | 2,6 | 0,66 | Q3 | — |
| 2017 | Q1 | Q3 | 1,038 | 2,9 | 2,9 | 0,7 | Q2 | 82 |
| 2016 | Q1 | Q3 | 1,017 | 2,5 | 2,8 | — | — | 82 |
| 2015 | Q1 | Q2 | 1,209 | 2,7 | 2,4 | — | — | 82 |
| 2014 | Q1 | Q3 | 1,03 | 2,6 | 2,2 | — | — | 82 |
| 2013 | Q1 | Q3 | 0,955 | 2,5 | 2,1 | — | — | 82 |
| 2012 | Q2 | Q3 | 0,776 | 2,1 | 1,9 | — | — | 82 |
| 2011 | Q2 | Q4 | 0,631 | 1,6 | 1,9 | — | — | 82 |
| 2010 | Q2 | Q3 | 0,725 | 1,9 | 2,1 | — | — | 82 |
| 2009 | — | Q3 | — | 2 | 2,2 | — | — | — |
| 2008 | — | Q3 | — | 2,4 | 2,6 | — | — | — |
| 2007 | — | Q2 | — | 2,5 | 2,8 | — | — | — |
| 2006 | — | Q2 | — | 2,8 | — | — | — | — |
| 2005 | — | Q3 | — | 2,2 | — | — | — | — |
| 2004 | — | Q2 | — | 2,5 | — | — | — | — |
| 2003 | — | Q2 | — | 2,2 | — | — | — | — |
| 2002 | — | Q3 | — | 1,5 | — | — | — | — |
| 2001 | — | Q2 | — | 2 | — | — | — | — |
| 2000 | — | Q3 | — | 1,4 | — | — | — | — |
| 1999 | — | Q3 | — | 1,1 | — | — | — | — |
| 1998 | — | Q3 | — | 1,2 | — | — | — | — |
| 1997 | — | Q3 | — | 0,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 120/198 |
| 2025 | NEUROSCIENCES | SCIE | Q3 | Q3 | 208/330 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 109/193 |
| 2024 | NEUROSCIENCES | SCIE | Q3 | Q3 | 174/314 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 115/186 |
| 2023 | NEUROSCIENCES | SCIE | Q3 | Q3 | 187/310 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 105/145 |
| 2022 | NEUROSCIENCES | SCIE | Q3 | Q3 | 174/272 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 104/146 |
| 2021 | NEUROSCIENCES | SCIE | Q3 | Q3 | 183/275 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 97/146 |
| 2020 | NEUROSCIENCES | SCIE | Q3 | Q3 | 166/273 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 103/143 |
| 2019 | NEUROSCIENCES | SCIE | Q3 | Q3 | 189/272 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 99/145 |
| 2018 | NEUROSCIENCES | SCIE | Q3 | Q3 | 182/267 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 80/142 |
| 2017 | NEUROSCIENCES | SCIE | Q3 | Q3 | 134/261 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 85/138 |
| 2016 | NEUROSCIENCES | SCIE | Q3 | — | 154/259 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 70/133 |
| 2015 | NEUROSCIENCES | SCIE | Q2 | — | 127/256 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 68/128 |
| 2014 | NEUROSCIENCES | SCIE | Q3 | — | 142/252 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 66/124 |
| 2013 | NEUROSCIENCES | SCIE | Q3 | — | 149/252 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 80/122 |
| 2012 | NEUROSCIENCES | SCIE | Q3 | — | 171/252 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 96/122 |
| 2011 | NEUROSCIENCES | SCIE | Q4 | — | 194/244 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 85/116 |
| 2010 | NEUROSCIENCES | SCIE | Q3 | — | 172/239 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 71/105 |
| 2009 | NEUROSCIENCES | SCIE | Q3 | — | 159/231 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 58/93 |
| 2008 | NEUROSCIENCES | SCIE | Q3 | — | 127/221 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 49/92 |
| 2007 | NEUROSCIENCES | SCIE | Q2 | — | 98/211 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 39/93 |
| 2006 | NEUROSCIENCES | SCIE | Q2 | — | 83/200 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 49/89 |
| 2005 | NEUROSCIENCES | SCIE | Q3 | — | 110/200 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 40/87 |
| 2004 | NEUROSCIENCES | SCIE | Q2 | — | 86/198 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 46/88 |
| 2003 | NEUROSCIENCES | SCIE | Q2 | — | 98/198 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 53/88 |
| 2002 | NEUROSCIENCES | SCIE | Q3 | — | 126/197 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 44/90 |
| 2001 | NEUROSCIENCES | SCIE | Q2 | — | 93/198 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 53/89 |
| 2000 | NEUROSCIENCES | SCIE | Q3 | — | 118/203 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 56/85 |
| 1999 | NEUROSCIENCES | SCIE | Q3 | — | 131/201 |
| 1998 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 50/83 |
| 1998 | NEUROSCIENCES | SCIE | Q3 | — | 118/202 |
| 1997 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 58/81 |
| 1997 | NEUROSCIENCES | SCIE | Q4 | — | 122/150 |